BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 14595558)

  • 21. Newborn hearing screening in Hong Kong.
    Lam BC
    Hong Kong Med J; 2006 Jun; 12(3):212-8. PubMed ID: 16760550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study.
    Sims EJ; Mugford M; Clark A; Aitken D; McCormick J; Mehta G; Mehta A;
    Lancet; 2007 Apr; 369(9568):1187-95. PubMed ID: 17416263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Societal cost of pre-lingual deafness].
    Bubbico L; Bartolucci MA; Broglio D; Boner A
    Ann Ig; 2007; 19(2):143-52. PubMed ID: 17547219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avoiding the cost burden of newborn screening for the poor and uninsured: Mississippi's model.
    Bender DR
    J Health Soc Policy; 1992; 3(4):51-8. PubMed ID: 10121847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Every child is priceless: debating effective newborn screening policy.
    Howell RR
    Hastings Cent Rep; 2009; 39(1):4-6; author reply 7-8. PubMed ID: 19213181
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential costs and benefits of newborn screening for severe combined immunodeficiency.
    McGhee SA; Stiehm ER; McCabe ER
    J Pediatr; 2005 Nov; 147(5):603-8. PubMed ID: 16291349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Every child is priceless: debating effective newborn screening policy.
    Green N
    Hastings Cent Rep; 2009; 39(1):6-7; author reply 7-8. PubMed ID: 19213182
    [No Abstract]   [Full Text] [Related]  

  • 29. An economic appraisal of alternative pre-natal screening programmes for Down's syndrome.
    Shackley P; McGuire A; Boyd PA; Dennis J; Fitchett M; Kay J; Roche M; Wood P
    J Public Health Med; 1993 Jun; 15(2):175-84. PubMed ID: 7688977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
    Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM
    J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal screening of phenylketonuria and congenital hypothyroidism in China.
    Fan GX; Jun Y; Rui-guan C
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():17-9. PubMed ID: 11400761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does newborn screening save money? The difference between cost-effective and cost-saving interventions.
    Grosse SD
    J Pediatr; 2005 Feb; 146(2):168-70. PubMed ID: 15689900
    [No Abstract]   [Full Text] [Related]  

  • 33. An analysis of the costs of implementing the National Newborn Hearing Screening Programme in England.
    Uus K; Bamford J; Taylor R
    J Med Screen; 2006; 13(1):14-9. PubMed ID: 16569300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the cost of cystic fibrosis diagnosis and treatment.
    Rosenberg MA; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S101-5. PubMed ID: 16202771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neonatal hearing screening: modelling cost and effectiveness of hospital- and community-based screening.
    Grill E; Uus K; Hessel F; Davies L; Taylor RS; Wasem J; Bamford J
    BMC Health Serv Res; 2006 Feb; 6():14. PubMed ID: 16504089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening: the spigot is open and threatens to become a flood.
    Cederbaum S
    J Pediatr; 2007 Aug; 151(2):108-10. PubMed ID: 17643755
    [No Abstract]   [Full Text] [Related]  

  • 37. Economic burden of schizophrenia: empirical analyses from a survey in Thailand.
    Phanthunane P; Whiteford H; Vos T; Bertram M
    J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis.
    Roberts TE; Barton PM; Auguste PE; Middleton LJ; Furmston AT; Ewer AK
    Arch Dis Child; 2012 Mar; 97(3):221-6. PubMed ID: 22247242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic burden of injuries in South Korea.
    Lim SJ; Chung WJ; Cho WH
    Inj Prev; 2011 Oct; 17(5):291-6. PubMed ID: 21622932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment.
    Davis A; Bamford J; Wilson I; Ramkalawan T; Forshaw M; Wright S
    Health Technol Assess; 1997; 1(10):i-iv, 1-176. PubMed ID: 9483157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.